Detalles de la búsqueda
1.
The Management of Pediatric Asthma Using Telehealth: An Integrative Review.
Telemed J E Health
; 30(3): 609-621, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37624652
2.
Telehealth Professionalism Education for Advanced Practice Nursing Students.
Nurs Educ Perspect
; 43(6): 382-383, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34798643
3.
Integration of Telehealth Education into the Health Care Provider Curriculum: A Review.
Telemed J E Health
; 27(2): 137-149, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32250196
4.
Graduate Nursing Telehealth Education: Assessment of a One-Day Immersion Approach.
Nurs Educ Perspect
; 41(5): E35-E36, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31232882
5.
Asthma 101: Teaching children to use metered dose inhalers.
Nursing
; 49(3): 56-60, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30801409
6.
A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer.
Oncoimmunology
; 11(1): 2113697, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36016696
7.
Telehealth Educational Resources for Graduate Nurse Faculty.
Nurse Educ
; 46(5): 295-299, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34238795
8.
TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL.
MAbs
; 13(1): 1890411, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33818299
9.
A bispecific antibody agonist of the IL-2 heterodimeric receptor preferentially promotes in vivo expansion of CD8 and NK cells.
Sci Rep
; 11(1): 10592, 2021 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34011961
10.
Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release.
J Immunother Cancer
; 9(6)2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34088740
11.
Effect of Facilitated Discharge in Pediatric Orthopedic Patients at an Academic Medical Facility.
J Pediatr Health Care
; 33(1): 58-63, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30153962
12.
Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies.
MAbs
; 11(4): 639-652, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30698484
13.
Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients.
Ann Intern Med
; 147(5): 311-9, 2007 Sep 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-17785486
14.
Sequence-Based Discovery Demonstrates That Fixed Light Chain Human Transgenic Rats Produce a Diverse Repertoire of Antigen-Specific Antibodies.
Front Immunol
; 9: 889, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29740455
15.
Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies.
Front Immunol
; 9: 3037, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30666250
16.
Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
Circulation
; 113(12): 1588-96, 2006 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-16534012
17.
Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.
JAMA
; 296(10): 1242-8, 2006 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-16968848
18.
Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
Circulation
; 110(11): 1456-62, 2004 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-15326072
19.
Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up.
Circulation
; 105(23): 2730-6, 2002 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-12057986
20.
Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
Circulation
; 108(6): 684-90, 2003 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-12885747